Alx Oncology Holdings (ALXO) Other Non Operating Income (2020 - 2026)
Alx Oncology Holdings' (ALXO) quarterly Other Non Operating Income came in at $188000.0 in Q1 2026, up 1809.09% year-on-year from $9847.6 in Q1 2025, and up 1205.88% quarter-over-quarter from -$17000.0 in Q4 2025.
Alx Oncology Holdings (ALXO) Other Non Operating Income (2020 - 2026) Analysis & Trends
Alx Oncology Holdings has disclosed Other Non Operating Income across 7 years of filings, most recently posting $188000.0 for Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $188000.0, up 1809.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $163000.0 (up 1058.82% YoY), and the FY2025 annual result was -$36000.0, down 80.0% from the prior year.
- Other Non Operating Income came in at $188000.0 for Q1 2026 at Alx Oncology Holdings, up from -$17000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $324000.0 in Q2 2023 to a low of -$29000.0 in Q4 2023.
- The 5-year median for Other Non Operating Income is -$5000.0 (2022), against an average of $29352.9.
- Across the five-year window, Other Non Operating Income soared 6580.0% in 2023 and tumbled 1600.0% in 2025, its largest moves.
- Alx Oncology Holdings' Other Non Operating Income stood at -$2000.0 in 2022, then sank by 1350.0% to -$29000.0 in 2023, then surged by 96.55% to -$1000.0 in 2024, then sank by 1600.0% to -$17000.0 in 2025, then surged by 1205.88% to $188000.0 in 2026.
- The last three Other Non Operating Income figures came in at $188000.0 (Q1 2026), -$17000.0 (Q4 2025), and -$6000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Alx Oncology Holdings | 166.27 Mn | 25.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | -11,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | -29,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | 324,000.00 |
| Mar 31, 2023 | 95,000.00 |
| Dec 31, 2022 | -2,000.00 |
| Sep 30, 2022 | -7,000.00 |
| Jun 30, 2022 | -5,000.00 |
| Mar 31, 2022 | -8,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | -12,000.00 |
| Jun 30, 2021 | 2,000.00 |